RecruitingPhase 2NCT07189208

Evaluation of Antimicrobial Prophylaxis to Prevent Syphilis in Pregnancy in Patients at Risk in Rio de Janeiro, Brazil


Sponsor

University of California, Los Angeles

Enrollment

500 participants

Start Date

Sep 24, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn if benzathine penicillin works to prevent maternal syphilis. It will also learn about the safety of benzathine penicillin. The main questions it aims to answer are: * Does benzathine penicillin lower the rate of syphilis in pregnancy? * What medical problems do participants have when taking benzathine penicillin? Researchers will compare benzathine penicillin to routine care to see if benzathine penicillin works to prevent syphilis. Participants will: * Take benzathine penicillin or receive routine care during the third trimester of pregnancy * Visit the clinic once a month for injections and tests * Report any reactions to benzathine penicillin to the study team


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Benzathine penicillin 2.4 million units and a behavioral approach called Counseling and intensified testing. for people with congenital syphilis. The study is currently recruiting participants at 4 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBenzathine penicillin 2.4 million units

IM injection of BPG

BEHAVIORALCounseling and intensified testing.

Brazilian Ministry of Health guidelines for the prevention and diagnosis of maternal syphilis consist of counseling about STI prevention and syphilis testing at the first pre-natal consultation, at a subsequent consultation during or after 28 weeks of pregnancy, at delivery, and in case of abortion or stillbirth. In this study, intensified testing refers to treponemal and non-treponemal tests once every four weeks beginning as of the 28th week of pregnancy.


Locations(4)

Centro de Referencia e Atenção Especializada a Saúde da Mulher (CRAESM)

Duque de Caxias, Rio de Janeiro, Brazil

Policlínica Hospital Municipal Duque de Caxias

Duque de Caxias, Rio de Janeiro, Brazil

Unidade Básica de Saúde José de Freitas

Duque de Caxias, Rio de Janeiro, Brazil

Hospital Federal dos Servidores do Estado

Rio de Janeiro, Rio de Janeiro, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07189208